April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
Tesla Is An AI Company That The Market Won’t Reward For Now
Amazon: The Margin Train Is Gaining Speed
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
ALNY Stock News and Mentions of Alnylam Pharmaceuticals, Inc. Stocktwits
Updated: April 28, 2024 (09:14)
Sector: HealthcareWelcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Alnylam Pharmaceuticals Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Alnylam Pharmaceuticals, Inc. (ALNY).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Alnylam Pharmaceuticals stocks.
News and Mentions of Alnylam Pharmaceuticals, Inc. (ALNY)
Ocugen ( OCGN ) to Report Q1 Earnings: What's in the Cards?
Zoetis ( ZTS ) to Report Q1 Earnings: What's in the Cards?
Alnylam Pharmaceuticals ( ALNY ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
StockNews.com Downgrades Alnylam Pharmaceuticals ( NASDAQ:ALNY ) to Hold
How Is The Market Feeling About Alnylam Pharmaceuticals? - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) Upgraded at StockNews.com
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board - Codexis ( NASDAQ:CDXS )
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
Why Alnylam Pharmaceuticals ( ALNY ) Stock Might be a Great Pick
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) Cut to Hold at StockNews.com
New Novartis data show early addition of twice-yearly* Leqvio® ( inclisiran ) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
Autolus Therapeutics Announces Changes to its Board of Directors - Autolus Therapeutics ( NASDAQ:AUTL )
Autolus Therapeutics Announces Changes to its Board of Directors
Alzheimer's Space Heats Up. Can Eli Lilly's Embattled Drug Catch Up?
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) Upgraded to "Buy" at StockNews.com
Should Invesco NASDAQ Next Gen 100 ETF ( QQQJ ) Be on Your Investing Radar?
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) Stock Rating Lowered by StockNews.com
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) Downgraded by StockNews.com to Hold
Alnylam ( ALNY ) , Roche's Blood Pressure Drug Meets Study Goal
Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY
Here's How Much $100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth Today - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.